Financhill
Back

Grifols SA 10K Form

Buy
55

GRFS
Grifols SA

Last Price:
$8.38
Seasonality Move:
-2.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRFS News And Ratings

See the #1 stock for the next 7 days that we like better than GRFS

GRFS Financial Statistics

Sales & Book Value

Annual Sales: $7.8B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $9.00
Price / Book: 0.91

Profitability

EPS (TTM): 0.32990
Net Income (TTM): $225.5M
Gross Margin: $3B
Return on Equity: 2.53%
Return on Assets: 0.97%

Grifols SA Earnings Forecast

Key Grifols SA Financial Ratios

  • The Gross Profit Margin over the past 20 years for GRFS is 38.75%.
  • The Selling, General & Administrative Expenses for GRFS have been equal to 15.86% of Gross Profit Margin.
  • The Research & Development expenses have been 5.32% of Revenue.
  • The Interest Expense is 384.00% of Operating Income.
  • The Net Earning history of GRFS is 2.18% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Grifols SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRFS
CUSIP: 398438
Website: grifols.com

Debt

Debt-to-Equity Ratio: 1.53
Current Ratio: 2.66
Quick Ratio: 0.96

Price-to-Earnings

Trailing P/E Ratio: 32.86
Forward P/E Ratio: 5.97

GRFS Technical Analysis vs Fundamental Analysis

Buy
55
Grifols SA (GRFS) is a Buy

Is Grifols SA a Buy or a Sell?

  • Grifols SA stock is rated a Buy
    The current Grifols SA [GRFS] share price is $8.18. The Score for GRFS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.